Reply to Comment on Re-Visiting Immunogenicity Associated with Botulinum Toxin Treatment. Toxins 2019, 11, 491
Toxins (Basel)
.
2020 Jan 23;12(2):72.
doi: 10.3390/toxins12020072.
Authors
Steven Bellows
1
,
Joseph Jankovic
1
Affiliation
1
Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA.
PMID:
31979241
PMCID:
PMC7076880
DOI:
10.3390/toxins12020072
Abstract
We appreciate the commentary on our article by Foster and Beard, both employees of Ipsen [...].
Publication types
Comment
MeSH terms
Botulinum Toxins, Type A*
Toxins, Biological*
Substances
Toxins, Biological
Botulinum Toxins, Type A